APPLICATION
ANDA075668
TYPE
ANDA
ORIGINAL APPROVAL
2002-09-12
LATEST ACTION
2009-06-24
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
NIZATIDINEDiscontinued
NIZATIDINE 150MG · CAPSULE · ORAL
NIZATIDINEDiscontinued
NIZATIDINE 300MG · CAPSULE · ORAL
Approval history
2009-06-24Labeling · Supplement 6AP
2009-05-21Labeling · Supplement 2AP
2002-09-12OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.